Pelthos Therapeutics Inc. (PTHS) — DEF 14A Filings
All DEF 14A filings from Pelthos Therapeutics Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Pelthos Seeks Shareholder Nod for Key Financing, Board Elections
— Nov 25, 2025 Risk: medium
Pelthos Therapeutics Inc. (PTHS) is holding its Annual Meeting on December 17, 2025, to address critical governance and financing matters. Shareholders will vot -
Chromocell Therapeutics Files Definitive Proxy Statement
— Sep 26, 2024 Risk: low
Chromocell Therapeutics Corp filed a Definitive Proxy Statement (DEF 14A) on September 26, 2024, for its annual meeting. The filing concerns the company's corpo
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX